Applied Therapeutics Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Applied Therapeutics, Inc. |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
APLT 2024 10-K filed. Financials and biz ops detailed.
AI Summary
Applied Therapeutics, Inc. filed its 2024 10-K on April 15, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates in the Pharmaceutical Preparations sector. Key financial data and operational details for the period are presented, including information on various agreements and stock plans.
Why It Matters
This filing provides a comprehensive overview of Applied Therapeutics' financial health and business operations for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Applied Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are typically detailed in a 10-K filing.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023-12-31 — Prior Year End (Date for which fair value measurements are reported)
Key Players & Entities
- Applied Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-04-15 (date) — Filing date
- New York (location) — Business and mailing address city
- 212-220-9226 (phone_number) — Business phone number
- Advanz Pharma (company) — Mentioned in relation to a license and supply agreement
- University of Miami (company) — Mentioned in relation to license agreements
FAQ
What is the primary business of Applied Therapeutics, Inc.?
Applied Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code [2834].
When did Applied Therapeutics, Inc. file its 10-K report?
The 10-K report was filed on April 15, 2025.
What is the fiscal year end for Applied Therapeutics, Inc.?
The fiscal year end for Applied Therapeutics, Inc. is December 31.
What are some of the agreements mentioned in the filing?
The filing mentions a License and Supply Agreement with Advanz Pharma for the period 2023-01-01 to 2023-12-31, and a License Agreement with the University of Miami from October 28, 2020.
What is the company's business address?
The company's business address is 545 Fifth Avenue, Suite 1400, New York, NY 10017.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding Applied Therapeutics, Inc..